Deprescribing CV medications may benefit elderly patients with evolving treatment goals
Dr. Scott Martin Vouri is quoted in Cardiology Today's October cover story on deprescribing CV medications.
Dr. Scott Martin Vouri is quoted in Cardiology Today's October cover story on deprescribing CV medications.
Scott Martin Vouri, Pharm.D., Ph.D., an assistant professor in the department of pharmaceutical outcomes and policy, was recently selected to the U.S. Deprescribing Research Network, or USDeN, Junior Investigative Intensive Program.
The study published in JAMA Network Open found a substantial number of patients are being prescribed a loop diuretic for leg swelling induced by calcium channel blocker.
Vouri was one of 18 junior faculty members selected to serve the Journal of the American Geriatrics Society.
Dr. Scott Martin Vouri co-authored the study published in the journal Pharmacotherapy.
The distinction comes with a two-year, $104,000 award, which Vouri will use to study a type of drug-induced adverse event called a prescribing cascade in older adults.